rs121434461
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_182943.3(PLOD2):โc.1856G>Aโ(p.Arg619His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000931 in 1,611,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (โ ).
Frequency
Genomes: ๐ 0.0000066 ( 0 hom., cov: 32)
Exomes ๐: 0.0000096 ( 0 hom. )
Consequence
PLOD2
NM_182943.3 missense
NM_182943.3 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 7.91
Genes affected
PLOD2 (HGNC:9082): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 2) The protein encoded by this gene is a membrane-bound homodimeric enzyme that is localized to the cisternae of the rough endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VIB have deficiencies in lysyl hydroxylase activity. Mutations in the coding region of this gene are associated with Bruck syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.922
PP5
Variant 3-146071416-C-T is Pathogenic according to our data. Variant chr3-146071416-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 7643.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-146071416-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLOD2 | NM_182943.3 | c.1856G>A | p.Arg619His | missense_variant | 18/20 | ENST00000282903.10 | NP_891988.1 | |
PLOD2 | NM_000935.3 | c.1793G>A | p.Arg598His | missense_variant | 17/19 | NP_000926.2 | ||
PLOD2 | XM_017006625.3 | c.1580G>A | p.Arg527His | missense_variant | 19/21 | XP_016862114.1 | ||
PLOD2 | XM_047448319.1 | c.1580G>A | p.Arg527His | missense_variant | 18/20 | XP_047304275.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLOD2 | ENST00000282903.10 | c.1856G>A | p.Arg619His | missense_variant | 18/20 | 1 | NM_182943.3 | ENSP00000282903.5 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151630Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151630
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250544Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135426
GnomAD3 exomes
AF:
AC:
3
AN:
250544
Hom.:
AF XY:
AC XY:
2
AN XY:
135426
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1459392Hom.: 0 Cov.: 32 AF XY: 0.00000964 AC XY: 7AN XY: 726104
GnomAD4 exome
AF:
AC:
14
AN:
1459392
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
726104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151630Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74044
GnomAD4 genome
AF:
AC:
1
AN:
151630
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74044
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
1
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Bruck syndrome 2 Pathogenic:2Uncertain:1
Uncertain significance, no assertion criteria provided | research | Department of Traditional Chinese Medicine, Fujian Provincial Hospital | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2004 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | Jul 22, 2023 | The missense c.1856G>A p.Arg619His variant in PLOD2 gene has been reported previously in homozygous state in multiple individuals affected with Bruck syndrome Ha-Vinh et al., 2004; Puig-Hervรกs et al., 2012; Caparros-Martin et al., 2016; Mumm et al., 2020; Wang et al., 2022. This variant has also been previously identified in homozygous state in proband and heterozygous state in parents and sisters Ha-Vinh et al., 2004; Wang et al., 2022. The p.Arg619His variant is present with allele frequency of 0.001% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Uncertain Significance / Pathogenic. Multiple lines of computational evidence Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing predict a damaging effect on protein structure and function for this variant. The reference amino acid at this position in PLOD2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. TThe amino acid Arg at position 619 is changed to a His changing protein sequence and it might alter its composition and physico-chemical properties. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;.;D;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
1.0, 1.0
.;D;D;D
Vest4
MutPred
0.80
.;.;Gain of glycosylation at Y603 (P = 0.0155);.;
MVP
MPC
0.45
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at